Preventing and treating hepatitis B infection

被引：39

作者：

Aggarwal, R ^{[1
]}

Ranjan, P ^{[1
]}

机构：

[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7474期

关键词：

D O I：

10.1136/bmj.329.7474.1080

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hepatitis B virus infection is a global public health problem. Hepatitis B vaccines are highly effective, long acting, and safe, making prevention and even eventual eradication possible. However, treatment options for patients who are already infected are limited. The currently available drugs are effective only in selected subsets of patients and have low efficacy rates, and their long term impact on occurrence of complications remains unknown.

引用

页码：1080 / 1086

页数：7

共 34 条

[1] Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model [J].

Aggarwal, R ;

Ghoshal, UC ;

Naik, SR .

JOURNAL OF HEPATOLOGY, 2003, 38 (02) :215-222

[2]

Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6

[3] Antiretroviral therapy and HIV/hepatitis B virus coinfection [J].

Benhamou, Y .

CLINICAL INFECTIOUS DISEASES, 2004, 38 :S98-S103

[4] Seroepidemiology of hepatitis B virus infection in children - Ten years of mass vaccination in Taiwan [J].

Chen, HL ;

Chang, MH ;

Ni, YH ;

Hsu, HY ;

Lee, PI ;

Lee, CY ;

Chen, DS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11) :906-908

[5] Peginterferon α-2a (40 kDa):: an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B [J].

Cooksley, WGE ;

Piratvisuth, T ;

Lee, SD ;

Mahachai, V ;

Chao, YC ;

Tanwandee, T ;

Chutaputti, A ;

Chang, WY ;

Zahm, FE ;

Pluck, N .

JOURNAL OF VIRAL HEPATITIS, 2003, 10 (04) :298-305

[6] Lamivudine as initial treatment for chronic hepatitis B in the United States [J].

Dienstag, JL ;

Schiff, ER ;

Wright, TL ;

Perrillo, RP ;

Hann, HWL ;

Goodman, Z ;

Crowther, L ;

Condreay, LD ;

Woessner, M ;

Rubin, M ;

Brown, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263

[7]

*EASL JUR, 2003, J HEPATOL, V38, P533

[8] Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences [J].

Ganem, D ;

Prince, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1118-1129

[9] Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Papatheodoridis, GV ;

Dimou, E ;

Laras, A ;

Papaioannou, C .

HEPATOLOGY, 2000, 32 (04) :847-851

[10] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Tassopoulos, NC ;

Heathcote, EJ ;

Chang, TT ;

Kitis, G ;

Rizzetto, M ;

Marcellin, P ;

Lim, SG ;

Goodman, Z ;

Wulfsohn, MS ;

Xiong, S ;

Fry, J ;

Brosgart, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :800-807

← 1 2 3 4 →